Shruti Niranjan Tapiawala

Shruti Niranjan Tapiawala

Active Director Director DIN 08522152
DIN 08522152 First appointment Sep 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Total affiliations 4 Since Sep 2019
Shareholding value •••• Premium profile

About Shruti Niranjan Tapiawala

Data last updated:

Shruti Niranjan Tapiawala is a Director at Advanced Transplant Diagnostics And Immunogenetics Private Limited (since 2019), Director at Atdi Lab Private Limited (since 2020) and Director at Advanced Renal Replacement Therapies Center Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Healthcare and Non-Profit Organizations. The 3 current companies with reported revenue have a combined latest revenue of ₹5.46 Cr; the largest is Advanced Transplant Diagnostics And Immunogenetics Private Limited at ₹2.72 Cr (FY 2025).

DIN 08522152
Primary Designation Director
Industry Healthcare
First Appointment 09 Sep 2019
Oldest Company Age 7 yrs
Combined revenue ₹5.46 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Sep 20192019₹2.72 Cr (FY 2025)Active
Atdi Lab Private Limited U85300MH2020PTC351304
Director04 Dec 20202020₹2.09 Cr (FY 2025)Active
Director25 Mar 20232023₹65 Lakh (FY 2025)Active
Director24 May 20242024Active

Directorship timeline

Open interactive timeline →
Atdi Lab Private Limited
Advanced Transplant Diagnostics And Immunogenetics Private Limited
Advanced Renal Replacement Therapies Center Private Limited
Atdi Sambhaji Nagar Lab Private Limited
Premium access

Shareholding and investment profile for Shruti Niranjan Tapiawala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shruti Niranjan Tapiawala

Shruti Niranjan Tapiawala currently holds 4 directorships: Advanced Transplant Diagnostics And Immunogenetics Private Limited (Director, since 09 Sep 2019, revenue ₹2.72 Cr (FY 2025)); Atdi Lab Private Limited (Director, since 04 Dec 2020, revenue ₹2.09 Cr (FY 2025)); Advanced Renal Replacement Therapies Center Private Limited (Director, since 25 Mar 2023, revenue ₹65 Lakh (FY 2025)); Atdi Sambhaji Nagar Lab Private Limited (Director, since 24 May 2024).

Shruti Niranjan Tapiawala was first appointed on 09 Sep 2019 as Director at Advanced Transplant Diagnostics And Immunogenetics Private Limited. The most recent appointment on record is 24 May 2024 at Atdi Sambhaji Nagar Lab Private Limited.

The 3 current companies of Shruti Niranjan Tapiawala that report revenue have a combined latest revenue of ₹5.46 Cr: Advanced Transplant Diagnostics And Immunogenetics Private Limited ₹2.72 Cr (FY 2025); Atdi Lab Private Limited ₹2.09 Cr (FY 2025); Advanced Renal Replacement Therapies Center Private Limited ₹65 Lakh (FY 2025).

The current boards of Shruti Niranjan Tapiawala's companies include Bharat Vallabhdas Shah (Advanced Transplant Diagnostics And Immunogenetics Private Limited), Hepal Mihir Vora (Advanced Transplant Diagnostics And Immunogenetics Private Limited), Prashant Jayendrasingh Rajput (Advanced Transplant Diagnostics And Immunogenetics Private Limited), Zaheer Aminmohamed Virani (Advanced Transplant Diagnostics And Immunogenetics Private Limited), Ishan Kishor Parekh (Advanced Renal Replacement Therapies Center Private Limited), Kamal Chokshi Chandrakant (Advanced Renal Replacement Therapies Center Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available